;PMID: 8225232
;source_file_877.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..35] = [t:0..35]
;1)sentence:[e:41..151] = [t:41..151]
;2)section:[e:155..182] = [t:155..182]
;3)section:[e:186..280] = [t:186..280]
;4)sentence:[e:284..520] = [t:284..520]
;5)sentence:[e:522..700] = [t:522..700]
;6)sentence:[e:701..820] = [t:701..820]
;7)sentence:[e:821..993] = [t:821..993]
;8)sentence:[e:994..1064] = [t:994..1064]
;9)sentence:[e:1065..1294] = [t:1065..1294]
;10)sentence:[e:1295..1520] = [t:1295..1520]
;11)sentence:[e:1521..1724] = [t:1521..1724]
;12)sentence:[e:1725..1842] = [t:1725..1842]
;13)section:[e:1842..1876] = [t:1842..1876]
;14)section:[e:1880..1924] = [t:1880..1924]

;section 0 Span:0..35
;Hepatology. 1993 Nov;18(5):1247-53.
(SEC
  (FRAG (NNP:[0..10] Hepatology) (,:[10..11] .) (CD:[12..16] 1993)
        (CC:[17..24] Nov;18-LRB-) (CD:[24..25] 5) (-RRB-:[25..26] -RRB-)
        (CD:[26..31] :1247) (::[31..32] -) (CD:[32..34] 53) (.:[34..35] .)))

;sentence 1 Span:41..151
;Alcohol consumption enhances fatty acid omega-oxidation, with a greater
;increase  in male than in female rats.
;[41..48]:substance:"Alcohol"
;[70..80]:substance:"fatty acid"
(SENT
  (S-HLN
    (NP-SBJ (NN:[41..48] Alcohol) (NN:[49..60] consumption))
    (VP (VBZ:[61..69] enhances)
      (NP
        (NML (JJ:[70..75] fatty) (NN:[76..80] acid))
        (NN:[81..96] omega-oxidation))
      (,:[96..97] ,)
      (PP (IN:[98..102] with)
        (NP
          (NP (DT:[103..104] a) (JJR:[105..112] greater)
              (NN:[113..121] increase))
          (PP (IN:[123..125] in)
            (NP (JJ:[126..130] male)))
          (PP (IN:[131..135] than)
            (PP (IN:[136..138] in)
              (NP (JJ:[139..145] female) (NNS:[146..150] rats)))))))
    (.:[150..151] .)))

;section 2 Span:155..182
;Ma X, Baraona E, Lieber CS.
(SEC
  (FRAG (NNP:[155..157] Ma) (NNP:[158..159] X) (,:[159..160] ,)
        (NNP:[161..168] Baraona) (NNP:[169..170] E) (,:[170..171] ,)
        (NNP:[172..178] Lieber) (NNP:[179..181] CS) (.:[181..182] .)))

;section 3 Span:186..280
;Alcohol Research and Treatment Center, Veteran Affairs Medical Center, Bronx,
; New York 10468.
(SEC
  (FRAG (NNP:[186..193] Alcohol) (NNP:[194..202] Research) (CC:[203..206] and)
        (NNP:[207..216] Treatment) (NNP:[217..223] Center) (,:[223..224] ,)
        (NNP:[225..232] Veteran) (NNP:[233..240] Affairs)
        (NNP:[241..248] Medical) (NNP:[249..255] Center) (,:[255..256] ,)
        (NNP:[257..262] Bronx) (,:[262..263] ,) (NNP:[265..268] New)
        (NNP:[269..273] York) (.:[274..279] 10468) (.:[279..280] .)))

;sentence 4 Span:284..520
;Because ethanol inhibits mitochondrial fatty acid oxidation, with substantial
; accumulation of fatty acids in the livers of female (but not male) rats, and
; induces microsomal activities, we assessed possible changes in
;omega-oxidation.
;[292..299]:substance:"ethanol"
;[323..333]:substance:"fatty acid"
;[379..390]:substance:"fatty acids"
(SENT
  (S
    (SBAR-PRP (IN:[284..291] Because)
      (S
        (NP-SBJ (NN:[292..299] ethanol))
        (VP
          (VP (VBZ:[300..308] inhibits)
            (NP (JJ:[309..322] mitochondrial)
              (NML (JJ:[323..328] fatty) (NN:[329..333] acid))
              (NN:[334..343] oxidation))
            (,:[343..344] ,)
            (PP (IN:[345..349] with)
              (NP
                (NP (JJ:[350..361] substantial) (NN:[363..375] accumulation))
                (PP (IN:[376..378] of)
                  (NP (JJ:[379..384] fatty) (NNS:[385..390] acids)))
                (PP-LOC (IN:[391..393] in)
                  (NP
                    (NP (DT:[394..397] the) (NNS:[398..404] livers))
                    (PP (IN:[405..407] of)
                      (NP (JJ:[408..414] female)
                        (PRN (-LRB-:[415..416] -LRB-)
                          (FRAG
                            (CONJP (CC:[416..419] but) (RB:[420..423] not))
                            (NP (JJ:[424..428] male)))
                          (-RRB-:[428..429] -RRB-))
                        (NNS:[430..434] rats))))))))
          (,:[434..435] ,) (CC:[436..439] and)
          (VP (VBZ:[441..448] induces)
            (NP (JJ:[449..459] microsomal) (NNS:[460..470] activities))))))
    (,:[470..471] ,)
    (NP-SBJ (PRP:[472..474] we))
    (VP (VBD:[475..483] assessed)
      (NP
        (NP (JJ:[484..492] possible) (NNS:[493..500] changes))
        (PP (IN:[501..503] in)
          (NP (NN:[504..519] omega-oxidation)))))
    (.:[519..520] .)))

;sentence 5 Span:522..700
;To study this, we pair-fed 24 male and 24 female littermate rats of the same
;age  liquid diets containing 36% of energy either as ethanol or as additional
; carbohydrate for 4 wk.
;[628..631]:quantitative-value:"36%"
;[652..659]:substance:"ethanol"
;[678..690]:substance:"carbohydrate"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[522..522] *))
      (VP (TO:[522..524] To)
        (VP (VB:[525..530] study)
          (NP (DT:[531..535] this)))))
    (,:[535..536] ,)
    (NP-SBJ (PRP:[537..539] we))
    (VP (NN:[540..544] pair) (HYPH:[544..545] -) (VBD:[545..548] fed)
      (NP
        (NP
          (NP (CD:[549..551] 24) (JJ:[552..556] male)
            (NML-1 (-NONE-:[556..556] *P*)))
          (CC:[557..560] and)
          (NP (CD:[561..563] 24) (JJ:[564..570] female)
            (NML-1 (JJ:[571..581] littermate) (NNS:[582..586] rats))))
        (PP (IN:[587..589] of)
          (NP (DT:[590..593] the) (JJ:[594..598] same) (NN:[599..602] age))))
      (NP
        (NP (NN:[604..610] liquid) (NNS:[611..616] diets))
        (VP (VBG:[617..627] containing)
          (NP
            (NP (CD:[628..630] 36) (NN:[630..631] %))
            (PP (IN:[632..634] of)
              (NP (NN:[635..641] energy)))
            (PP (CC:[642..648] either)
              (PP (IN:[649..651] as)
                (NP (NN:[652..659] ethanol)))
              (CC:[660..662] or)
              (PP (IN:[663..665] as)
                (NP (JJ:[666..676] additional) (NN:[678..690] carbohydrate)))))))
      (PP-TMP (IN:[691..694] for)
        (NP (CD:[695..696] 4) (NN:[697..699] wk))))
    (.:[699..700] .)))

;sentence 6 Span:701..820
;In controls, the microsomal omega-hydroxylation of lauric  acid was 28%
;greater in female than in male rats (p < 0.05).
;[752..764]:substance:"lauric  acid"
;[769..772]:quantitative-value:"28%"
(SENT
  (S
    (PP (IN:[701..703] In)
      (NP (NNS:[704..712] controls)))
    (,:[712..713] ,)
    (NP-SBJ
      (NP (DT:[714..717] the) (JJ:[718..728] microsomal)
          (NN:[729..748] omega-hydroxylation))
      (PP (IN:[749..751] of)
        (NP (JJ:[752..758] lauric) (NN:[760..764] acid))))
    (VP (VBD:[765..768] was)
      (ADJP-PRD
        (ADJP
          (NP-EXT (CD:[769..771] 28) (NN:[771..772] %))
          (JJR:[773..780] greater))
        (PP-1 (-NONE-:[780..780] *ICH*)))
      (PP-LOC (IN:[781..783] in)
        (NP (JJ:[784..790] female)))
      (PP-1 (IN:[791..795] than)
        (PP-LOC (IN:[796..798] in)
          (NP (JJ:[799..803] male) (NNS:[804..808] rats))))
      (PRN (-LRB-:[809..810] -LRB-)
        (S
          (NP-SBJ (NN:[810..811] p))
          (VP (SYM:[812..813] <)
            (NP (CD:[814..818] 0.05))))
        (-RRB-:[818..819] -RRB-)))
    (.:[819..820] .)))

;sentence 7 Span:821..993
;Ethanol feeding  significantly increased this activity in both genders (p <
;0.01), but the rise  in male rats (89%) was significantly higher than that in
;female rats (24%).
;[821..828]:substance:"Ethanol"
;[932..935]:quantitative-value:"89%"
;[988..991]:quantitative-value:"24%"
(SENT
  (S
    (S
      (NP-SBJ (NN:[821..828] Ethanol) (NN:[829..836] feeding))
      (ADVP (RB:[838..851] significantly))
      (VP (VBD:[852..861] increased)
        (NP (DT:[862..866] this) (NN:[867..875] activity))
        (PP (IN:[876..878] in)
          (NP (DT:[879..883] both) (NNS:[884..891] genders)))
        (PRN (-LRB-:[892..893] -LRB-)
          (S
            (NP-SBJ (NN:[893..894] p))
            (VP (SYM:[895..896] <)
              (NP (CD:[897..901] 0.01))))
          (-RRB-:[901..902] -RRB-))))
    (,:[902..903] ,) (CC:[904..907] but)
    (S
      (NP-SBJ
        (NP (DT:[908..911] the) (NN:[912..916] rise))
        (PP-LOC (IN:[918..920] in)
          (NP (JJ:[921..925] male) (NNS:[926..930] rats)
            (PRN (-LRB-:[931..932] -LRB-)
              (NP (CD:[932..934] 89) (NN:[934..935] %))
              (-RRB-:[935..936] -RRB-)))))
      (VP (VBD:[937..940] was)
        (ADJP-PRD
          (ADJP (RB:[941..954] significantly) (JJR:[955..961] higher))
          (PP (IN:[962..966] than)
            (NP
              (NP (DT:[967..971] that))
              (PP-LOC (IN:[972..974] in)
                (NP (JJ:[975..981] female) (NNS:[982..986] rats)
                  (PRN (-LRB-:[987..988] -LRB-)
                    (NP (CD:[988..990] 24) (NN:[990..991] %))
                    (-RRB-:[991..992] -RRB-)))))))))
    (.:[992..993] .)))

;sentence 8 Span:994..1064
;This  activity was unaffected by the presence of ethanol in the assay.
;[1043..1050]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ (DT:[994..998] This) (NN:[1000..1008] activity))
    (VP (VBD:[1009..1012] was)
      (ADJP-PRD (JJ:[1013..1023] unaffected)
        (PP (IN:[1024..1026] by)
          (NP
            (NP (DT:[1027..1030] the) (NN:[1031..1039] presence))
            (PP (IN:[1040..1042] of)
              (NP (NN:[1043..1050] ethanol)))
            (PP (IN:[1051..1053] in)
              (NP (DT:[1054..1057] the) (NN:[1058..1063] assay)))))))
    (.:[1063..1064] .)))

;sentence 9 Span:1065..1294
;The effects of  ethanol were associated with increases in the content of
;cytochrome P-450 4A1  (as assessed in Western blots by the reactivity against
;a sheep antibody against  P-450 4A1), and more so in male than in female
;rats.
;[1081..1088]:substance:"ethanol"
;[1138..1158]:cyp450:"cytochrome P-450 4A1"
;[1224..1232]:substance:"antibody"
;[1242..1251]:cyp450:"P-450 4A1"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1065..1068] The) (NNS:[1069..1076] effects))
      (PP (IN:[1077..1079] of)
        (NP (NN:[1081..1088] ethanol))))
    (VP (VBD:[1089..1093] were)
      (UCP
        (VP (VBN:[1094..1104] associated)
          (NP-2 (-NONE-:[1104..1104] *))
          (PP-CLR (IN:[1105..1109] with)
            (NP
              (NP (NNS:[1110..1119] increases))
              (PP (IN:[1120..1122] in)
                (NP
                  (NP (DT:[1123..1126] the) (NN:[1127..1134] content))
                  (PP (IN:[1135..1137] of)
                    (NP (NN:[1138..1148] cytochrome) (NN:[1149..1154] P-450)
                        (NN:[1155..1158] 4A1)))))
              (PRN (-LRB-:[1160..1161] -LRB-)
                (SBAR (IN:[1161..1163] as)
                  (S
                    (NP-SBJ-1 (-NONE-:[1163..1163] *))
                    (VP (VBN:[1164..1172] assessed)
                      (NP-1 (-NONE-:[1172..1172] *))
                      (PP (IN:[1173..1175] in)
                        (NP (JJ:[1176..1183] Western) (NNS:[1184..1189] blots)))
                      (PP-MNR (IN:[1190..1192] by)
                        (NP
                          (NP (DT:[1193..1196] the) (NN:[1197..1207] reactivity))
                          (PP (IN:[1208..1215] against)
                            (NP
                              (NP (DT:[1216..1217] a) (NN:[1218..1223] sheep)
                                  (NN:[1224..1232] antibody))
                              (PP (IN:[1233..1240] against)
                                (NP (NN:[1242..1247] P-450)
                                    (NN:[1248..1251] 4A1))))))))))
                (-RRB-:[1251..1252] -RRB-)))))
        (,:[1252..1253] ,)
        (NAC (CC:[1254..1257] and)
          (ADVP
            (ADVP (RBR:[1258..1262] more) (RB:[1263..1265] so))
            (PP-LOC (IN:[1266..1268] in)
              (NP (JJ:[1269..1273] male)
                (NML-3 (-NONE-:[1273..1273] *P*))))
            (PP (IN:[1274..1278] than)
              (NP (IN:[1279..1281] in)
                (NP (JJ:[1282..1288] female)
                  (NML-3 (NNS:[1289..1293] rats)))))))))
    (.:[1293..1294] .)))

;sentence 10 Span:1295..1520
;Despite possible  competition by ethanol with the hydroxy fatty acid
;oxidation to dicarboxylic  acids through alcohol dehydrogenase, suberic and
;sebacic acids accumulated  significantly in the livers of alcohol-fed male
;rats.
;[1328..1335]:substance:"ethanol"
;[1345..1363]:substance:"hydroxy fatty acid"
;[1377..1396]:substance:"dicarboxylic  acids"
;[1405..1426]:substance:"alcohol dehydrogenase"
;[1428..1435]...[1448..1453]:substance:"suberic"..."acids"
;[1440..1453]:substance:"sebacic acids"
;[1498..1505]:substance:"alcohol"
(SENT
  (S
    (PP (IN:[1295..1302] Despite)
      (NP
        (NP (JJ:[1303..1311] possible) (NN:[1313..1324] competition))
        (PP (IN:[1325..1327] by)
          (NP (NN:[1328..1335] ethanol)))
        (PP (IN:[1336..1340] with)
          (NP
            (NP (DT:[1341..1344] the)
               (NN:[1345..1352] hydroxy)
              (NML (JJ:[1353..1358] fatty) (NN:[1359..1363] acid))
              (NN:[1364..1373] oxidation))
            (PP (TO:[1374..1376] to)
              (NP (JJ:[1377..1389] dicarboxylic) (NNS:[1391..1396] acids)))
            (PP (IN:[1397..1404] through)
              (NP (NN:[1405..1412] alcohol) (NN:[1413..1426] dehydrogenase)))))))
    (,:[1426..1427] ,)
    (NP-SBJ
      (NP (JJ:[1428..1435] suberic)
        (NML-1 (-NONE-:[1435..1435] *P*)))
      (CC:[1436..1439] and)
      (NP (JJ:[1440..1447] sebacic)
        (NML-1 (NNS:[1448..1453] acids))))
    (VP (VBD:[1454..1465] accumulated)
      (ADVP (RB:[1467..1480] significantly))
      (PP-LOC (IN:[1481..1483] in)
        (NP
          (NP (DT:[1484..1487] the) (NNS:[1488..1494] livers))
          (PP (IN:[1495..1497] of)
            (NP
              (ADJP (NN:[1498..1505] alcohol) (HYPH:[1505..1506] -)
                    (VBN:[1506..1509] fed))
              (JJ:[1510..1514] male) (NNS:[1515..1519] rats))))))
    (.:[1519..1520] .)))

;sentence 11 Span:1521..1724
;These effects of ethanol  and gender on omega-oxidation paralleled those on
;the hepatic cytosolic fatty  acid-binding protein and fatty acid
;esterification previously reported in  similarly treated rats.
;[1538..1545]:substance:"ethanol"
;[1619..1646]:substance:"fatty  acid-binding protein"
;[1651..1661]:substance:"fatty acid"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1521..1526] These) (NNS:[1527..1534] effects))
      (PP (IN:[1535..1537] of)
        (NP (NN:[1538..1545] ethanol) (CC:[1547..1550] and)
            (NN:[1551..1557] gender)))
      (PP (IN:[1558..1560] on)
        (NP (NN:[1561..1576] omega-oxidation))))
    (VP (VBD:[1577..1587] paralleled)
      (NP
        (NP
          (NP (DT:[1588..1593] those))
          (PP (IN:[1594..1596] on)
            (NP
              (NP (DT:[1597..1600] the) (JJ:[1601..1608] hepatic)
                  (JJ:[1609..1618] cytosolic)
                
                (ADJP
                  (NML (JJ:[1619..1624] fatty) (NN:[1626..1630] acid))
                  (HYPH:[1630..1631] -) (VBG:[1631..1638] binding))
                (NN:[1639..1646] protein))
              (CC:[1647..1650] and)
              (NP
                (NML (JJ:[1651..1656] fatty) (NN:[1657..1661] acid))
                (NN:[1662..1676] esterification)))))
        (VP
          (ADVP-TMP (RB:[1677..1687] previously))
          (VBN:[1688..1696] reported)
          (NP (-NONE-:[1696..1696] *))
          (PP-LOC (IN:[1697..1699] in)
            (NP
              (ADJP (RB:[1701..1710] similarly) (VBN:[1711..1718] treated))
              (NNS:[1719..1723] rats))))))
    (.:[1723..1724] .)))

;sentence 12 Span:1725..1842
;Dicarboxylic acid products of omega-oxidation have been  incriminated as
;mediators of similar effects by other drugs.
;[1725..1742]:substance:"Dicarboxylic acid"
;[1798..1807]:substance:"mediators"
;[1836..1841]:substance:"drugs"
(SENT
  (S
    (NP-SBJ-1
      (NP
         (JJ:[1725..1737] Dicarboxylic) (NN:[1738..1742] acid)
        (NNS:[1743..1751] products))
      (PP (IN:[1752..1754] of)
        (NP (NN:[1755..1770] omega-oxidation))))
    (VP (VBP:[1771..1775] have)
      (VP (VBN:[1776..1780] been)
        (VP (VBN:[1782..1794] incriminated)
          (NP-1 (-NONE-:[1794..1794] *))
          (PP (IN:[1795..1797] as)
            (NP
              (NP (NNS:[1798..1807] mediators))
              (PP (IN:[1808..1810] of)
                (NP (JJ:[1811..1818] similar) (NNS:[1819..1826] effects)))))
          (PP (IN:[1827..1829] by)
            (NP-LGS (JJ:[1830..1835] other) (NNS:[1836..1841] drugs))))))
    (.:[1841..1842] .)))

;section 13 Span:1842..1876
;(ABSTRACT TRUNCATED  AT 250 WORDS)
(SEC
  (FRAG (-LRB-:[1842..1843] -LRB-) (NN:[1843..1851] ABSTRACT)
        (VBN:[1852..1861] TRUNCATED) (IN:[1863..1865] AT) (CD:[1866..1869] 250)
        (NNS:[1870..1875] WORDS) (-RRB-:[1875..1876] -RRB-)))

;section 14 Span:1880..1924
;PMID: 8225232 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1880..1884] PMID) (::[1884..1885] :) (CD:[1886..1893] 8225232)
        (NN:[1894..1895] -LSB-) (NNP:[1895..1901] PubMed) (::[1902..1903] -)
        (NN:[1904..1911] indexed) (IN:[1912..1915] for)
        (NNP:[1916..1924] MEDLINE-RSB-)))
